We are live on ! Find out more
ACM

Axel Capital Management Portfolio holdings

AUM $47.4M
1-Year Est. Return 2.75%
This Fund
S&P 500
This Quarter Est. Return
+3.28%
1 Year Est. Return
-2.75%
3 Year Est. Return
+193.8%
5 Year Est. Return
+305.5%
10 Year Est. Return
AUM
$113M
AUM Growth
-$75.8M
Cap. Flow
-$79.9M
Cap. Flow %
-71.01%
Top 10 Hldgs %
95.2%
Holding
19
New
Increased
Reduced
1
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$78M
2
LLY icon
Eli Lilly
LLY
+$1.46M
3
MA icon
Mastercard
MA
+$473K

Sector Composition

Rank Sector Weight
1 Consumer Staples 7.44%
2 Healthcare 4.25%
3 Financials 3.35%
4 Real Estate 2.69%
5 Technology 1.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
State Street SPDR S&P 500 ETF Trust
SPY
$782B
$88M 78.19%
420,270
-376,000
-47% -$78M
WTW icon
2
Willis Towers Watson
WTW
$27.7B
$3.77M 3.35%
30,300
AMT icon
3
American Tower
AMT
$78.2B
$2.27M 2.02%
20,000
ADP icon
4
Automatic Data Processing
ADP
$99.4B
$2.21M 1.96%
24,000
SJM icon
5
J.M. Smucker
SJM
$12.5B
$2.15M 1.91%
14,100
MDLZ icon
6
Mondelez International
MDLZ
$77.4B
$2.05M 1.82%
45,000
WBA
7
DELISTED
Walgreens Boots Alliance
WBA
$2M 1.77%
24,000
KR icon
8
Kroger
KR
$34.6B
$1.91M 1.7%
52,000
CLX icon
9
Clorox
CLX
$11.5B
$1.69M 1.5%
12,200
ALB icon
10
Albemarle
ALB
$13.9B
$1.1M 0.98%
13,928
BMY icon
11
Bristol-Myers Squibb
BMY
$127B
$1.1M 0.98%
15,000
JNJ icon
12
Johnson & Johnson
JNJ
$634B
$898K 0.8%
7,400
DVA icon
13
DaVita
DVA
$15.2B
$789K 0.7%
10,200
SBAC icon
14
SBA Communications
SBAC
$18.7B
$756K 0.67%
7,000
TRCO
15
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$666K 0.59%
17,000
CDK
16
DELISTED
CDK Global, Inc.
CDK
$620K 0.55%
11,166
PG icon
17
Procter & Gamble
PG
$343B
$576K 0.51%
6,800
LLY icon
18
Eli Lilly
LLY
$1.07T
-20,260
Closed -$1.46M
MA icon
19
Mastercard
MA
$473B
-5,000
Closed -$473K

Similar funds

Axel Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Axel Capital Management held 19 positions worth $113M, down 40% from $188M the previous quarter. Its ten largest holdings account for 95% of the portfolio.

Axel Capital Management withdrew a net $79.9M in Q2 2016, closing 2 positions and reducing 1 holding. Its most notable exit was Eli Lilly, an estimated $1.46M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 7.4% of assets, up from 4.1% a quarter earlier, followed by Healthcare and Financials.

  • Axel Capital Management's biggest Q2 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $78M.
  • Axel Capital Management fully exited Eli Lilly in Q2 2016, selling an estimated $1.46M.
  • Axel Capital Management's ten largest holdings make up 95% of its $113M portfolio in Q2 2016.
  • Axel Capital Management opened 0 new positions and closed 2 in Q2 2016.
  • Axel Capital Management's portfolio value fell 40% quarter-over-quarter to $113M.

Based on Axel Capital Management's 13F filing for Q2 2016, filed 11 Aug 2016.